CG Oncology Therapeutics (CGON) Sof marja

CG Oncology Inc - CGON emitenti grafik logotipi

CG Oncology, Inc. (CGON) urologik dori vositalarini bozorga chiqarish uchun tadqiqotchilar va savdo agentlari shtatini jadal kengtirmoqda. Sof foyda savdolari hosillari obyektiv qoldiq kapital dinamikasini namoyish etmoqda, bunda -3851.10 qiymati joriy daromadlilik darajasini ko'rsatadi. Samara keltirgan boshqaruv qopqon saratoni terapiyasini muvaffaqiyatli ishlab chiqmoqda, optimallashtirilgan harorat nazoratidagi biologik logistika esa yuqori marjalarni kafolatlaydi.

CG Oncology, Inc. (CGON) - Sof foyda bo'yicha sotuv rentabelligi 21.02.2024dan 20.11.2026gacha

CG Oncology Therapeutics (CGON) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi tafsilotlari:
Kompaniyaning har tomonlama tahlili:cgoncology.com - CGON
CG Oncology Corp ishlab chiqargan mahsulot

CG Oncology, Inc. (CGON) kompaniyasining onkolitik terapiya sohasidagi R&D loyihalari portfelining yuqori salohiyati innovatsiyalarni monetizatsiya qilishning kelgusidagi samaradorligini belgilaydi. Amalga oshirishning sof daromadlilik profilini tahlil qilish orqali investor jami daromadga nisbatan sof foyda marjasini baholaydi, bu esa inqilobiy dori vositalarini tijoratlashtirish yo'lida biznesning operatsion samaradorligi va moliyaviy barqarorligini ob'yektiv o'lchash imkonini beradi.

CG Oncology, Inc. raqobatchilari

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sof marja UroGen Pharma (URGN)|Sotuvning sof marjinal rentabelligi Bicara Therapeutics (BCAX)|Sotuvning sof marjinal rentabelligi PSNL (personalis.com)|Sof foyda normasi ERAS|DCTH: Sof foyda bo'yicha sotuv rentabelligi|YmAbs - Kompaniyaning sof rentabelligi|aurabiosciences.com (AURA) - Sof marja|Candel Therapeutics Inc. - Sof foyda normasi|Sof marja Accuray Inc.|Sof marja SELLAS Life Sciences Group SLS|Sotuvning sof marjinal rentabelligi ACTU|CTOR - Sof marja|Sotuvning sof marjinal rentabelligi HURA (TuHURA Biosciences, Inc.)|Sof foyda normasi TARA|FATE: Sof foyda bo'yicha sotuv rentabelligi|WHWK (aadibio.com) - Sotuvning sof rentabelligi|TCRX (TScan Therapeutics, Inc.) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Sotuvning sof marjinal rentabelligi|CVM (CEL-SCI Corporation) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi OSTX|Sotuvning sof marjinal rentabelligi Radiopharm Theranostics Ltd (RADX)|Sotuvning sof marjinal rentabelligi ARTV (Artiva Biotherapeutics)|Sotuvning sof marjinal rentabelligi Adlai Nortye Ltd. ANL|Veru Inc - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Tempest Therapeutics TPST|XLO: Sotuvning sof marjinal rentabelligi|Enochian BioSciences (RENB) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MURA|Kairos Pharma Ltd - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)